This activity is provided by Paradigm Medical Communications, LLC.
This educational activity is supported by educational grants from GlaxoSmithKline and Sunovion Pharmaceuticals Inc.
COPD is underdiagnosed, misdiagnosed, and often inappropriately treated. Pulmonologists, who see many of the most severe and challenging cases, are well-positioned to turn the tide. However, they are hard-pressed to stay current with this rapidly evolving field. Among their challenges are: heterogeneous presentations with overlapping comorbidities; an influx of sophisticated pharmacotherapies and devices; and recent and yet unfamiliar guideline updates calling for significant practice changes based on compelling new data. Continuing education will be instrumental in familiarizing these key clinicians with advances in COPD diagnosis and care that have the potential to significantly improve a number of important outcomes, including lung function, exacerbations, hospital admissions (and readmissions), and quality of life.
Table of Contents
COPD Evaluation: GOLD 2017 Practice Changes GOLD 2017 Approach to Individualized COPD Treatment Demonstration of Inhaled COPD Medication Delivery Devices (Video)
Resources COPD Medication Delivery Devices at a Glance (PDF)
This activity has been designed to address the educational needs of physicians specializing in pulmonology. It may also benefit other healthcare providers involved in or interested in the care of patients with COPD, including primary care practitioners, such as general physicians, family physicians, internists, nurse practitioners (NPs), and PAs.
Upon proper completion of this activity, participants should be better able to:
Recognize early signs and symptoms that warrant further evaluation to differentially diagnose chronic obstructive pulmonary disease
Categorize patients with chronic obstructive pulmonary disease according to disease severity, as recommended by current GOLD strategies
Select appropriate pharmacotherapy for patients with stable chronic obstructive pulmonary disease based on patient, disease, and medication characteristics
Choose a medication delivery device for patients with chronic obstructive pulmonary disease that accords with patient needs, preferences, and capabilities
Conflict Of Interest Disclosure Policy
Paradigm Medical Communications, LLC, has implemented a system to resolve conflicts of interest for each CME activity to help ensure content objectivity, independence, fair balance, and that the content is aligned with the interest of the public. Conflicts, if any, are resolved through one or more processes. All CME content in this activity was independently reviewed to ensure that it is free of commercial bias, scientifically rigorous, aligned with the public interest, and compliant with all regulatory guidance and the ACCME’s Standards for Commercial Support of Continuing Medical Education.
In accordance with Accreditation Council for Continuing Medical Education requirements on disclosure, faculty and contributors are asked to disclose any relationships with commercial interests associated with the area of medicine featured in the activity. These relationships are described below.
Brian W. Carlin, MD, FCCP, FAARC, MAACVPR (Chair) Sleep Medicine and Lung Health Consultants Pittsburgh Critical Care Associates Pittsburgh, PA
Dr. Carlin discloses the following: Advisory Board: Monaghan Medical Corporation; Nonin Medical Inc; Philips Respironics; Sunovion Pharmaceuticals Inc Speakers Bureau: Monaghan Medical Corporation; Sunovion Pharmaceuticals Inc
Donald A. Mahler, MD, FCCP Emeritus Professor of Medicine Geisel School of Medicine at Dartmouth Hanover, NH Director of Respiratory Services Valley Regional Hospital Claremont, NH
Dr. Mahler discloses the following: Royalty: Mill City Press, Inc; MAPI Research Trust Advisory Board: Boehringer Ingelheim Pharmaceuticals, Inc; Mylan Pharmaceuticals Inc; Sunovion Pharmaceuticals Inc; Theravance Biopharma Retained Consultant: Boehringer Ingelheim Pharmaceuticals, Inc; GlaxoSmithKline; Sunovion Pharmaceuticals Inc Speakers Bureau: Boehringer Ingelheim Pharmaceuticals, Inc; Grifols USA, LLC; Sunovion Pharmaceuticals Inc
Accredited Provider Disclosure
Paradigm Medical Communications, LLC, staff members have no financial relationships to disclose.
Independent peer reviewer has no financial relationships to disclose.
AMA PRA Category 1 Credit(s)TM
Paradigm Medical Communications, LLC, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Paradigm Medical Communications, LLC, designates this enduring material for a maximum of 1.50 AMA PRA Category 1 CreditsTM . Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Additional Credit Information
PA Continuing Education PAs may claim a maximum of 1.50 Category 1 credits for completing this activity. NCCPA accepts AMA PRA Category 1 CreditTM from organizations accredited by ACCME or a recognized state medical society.
Nurse Practitioner Continuing Education The American Academy of Nurse Practitioners Certification Program (AANPCP) accepts certificates of participation for educational activities certified for AMA PRA Category 1 CreditTM from organizations accredited by the ACCME. Individuals are responsible for checking with the AANPCP for further guidelines.
This CME activity represents the views and opinions of the individual faculty, and does not constitute the opinion or endorsement of, or promotion by, Paradigm Medical Communications, LLC. Reasonable efforts have been taken to present educational subject matter in a balanced, unbiased fashion, and in compliance with regulatory requirements. However, each activity participant must always use his or her own personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.
If included, signed statements of informed consent granting permission for use have been obtained for all photographs and videos in which an individual can be identified.
As an ACCME-accredited provider, Paradigm Medical Communications, LLC, activities must include a balanced view of therapeutic options. Use of generic names contributes to this impartiality. The use of trade names should not be viewed as an endorsement of specific products by Paradigm Medical Communications, LLC.
To receive a CME certificate of participation, you should:
Follow the "Start Activity" button to go to the Paradigm Medical Communications website, where you will complete the pretest.
View the online activity in its entirety.
Complete and submit the online post-test and evaluation. You must answer 70% of the post-test questions correctly to earn credit. You will have unlimited opportunities to successfully complete the post-test.
A certificate of participation will be available for download/printing immediately following your successful completion of the post-test and evaluation. Your certificate will be saved on the Paradigm Medical Communications website and will not be available in your myCME CME History.
There is no fee required for participation in this activity.
For questions regarding CME credit, contact the Paradigm CME Department at (845) 398-5949.
Technical Support: If you have any technical problems or playback issues, please email Paradigm at email@example.com.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA.
Disclaimer The materials provided for this activity are for informational purposes only, and should not be used for diagnosis or treatment of a health problem without consulting a licensed medical professional. Any views or opinions presented are solely those of the Faculty, and do not necessarily represent those of Paradigm Medical Communications, LLC. References to any entity, product, service, or source of information on this website should not be considered an endorsement, either direct or implied, by Paradigm Medical Communications, LLC. Paradigm Medical Communications, LLC, accepts no liability for the content referenced in this activity.
This certified CME activity is designed using HTML5 audio and video.
For Desktops (Windows/Mac) Internet Explorer 9 or higher, Firefox 28 or higher, Safari 5.1 or higher, Google Chrome 31 or higher, Opera 21 or higher
For Tablets (iPad/Android/Surface) iOS Safari 4 or higher, Android 2.3 or higher, IE Mobile 10 or higher